PRAX P/E Ratio
P/E Ratio as of Jun 13, 2025: -4.14
Average-3.79
Median-3.71
Minimum-4.28
Maximum-3.37
-4.14
Past Month-0.67 (19.31%)
The P/E ratio for PRAX is -4.14 as of Jun 13, 2025. This represents a decrease of -22.91% compared to its 12-month average P/E ratio of -5.37. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Praxis Precision Medicines P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Praxis Precision Medicines’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Praxis Precision Medicines to industry peers.
Praxis Precision Medicines P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Praxis Precision Medicines’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Praxis Precision Medicines to industry peers.
PRAX P/E Ratio Insights
See Praxis Precision Medicines’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in PRAX
Order type
Buy in
Order amount
Est. shares
0 shares
PRAX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $39.82 | -3.72 |
| May 1, 2025 | $38.06 | -3.71 |
| Apr 1, 2025 | $35.87 | -3.49 |
| Mar 3, 2025 | $33.55 | -3.27 |
| Feb 3, 2025 | $80.26 | -7.80 |
| Jan 2, 2025 | $79.52 | -7.72 |
PRAX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -4.14 | -44.58% |
| 2024 | -7.47 | +1,031.82% |
| 2023 | -0.66 | +40.43% |
| 2022 | -0.47 | -90.71% |
| 2021 | -5.06 | -83.10% |
| 2020 | -29.94 | — |
FAQs About Praxis Precision Medicines (PRAX) P/E ratio
The latest P/E ratio of PRAX is -4.14, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Praxis Precision Medicines’s last 12-month average P/E ratio is -5.37, compared to its current P/E ratio of -4.14. This reflects a decrease of -22.91%.
Praxis Precision Medicines’s current P/E ratio of -4.14 is lower than its last 12-month average P/E of -5.37. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Praxis Precision Medicines’s average P/E ratio over the last 3 years is -2.45. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Praxis Precision Medicines’s average P/E ratio over the last 5 years is -5.45. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.